End-stage renal disease incidence, prognosis improving for patients with diabetes

October 11, 2005

Patients with type 1 diabetes have an improved prognosis with regard to end-stage renal disease over the past four decades, and it appears the incidence of end-stage renal disease is lower than previously estimated, according to a study in the October 12 issue of JAMA.

Diabetic kidney disease is one of the most severe complications of type 1 diabetes, and diabetes is the most important cause of end-stage renal disease (ESRD; severely impaired kidney function, requiring dialysis) in industrialized countries, according to background information in the article. Data on patients' risk of developing ESRD are sparse. Large population-based studies with long-term follow-up have not been performed; therefore, the true incidence and age- and sex-stratified risk estimates of ESRD among patients with type 1 diabetes are not known.

Patrik Finne, M.D., Ph.D., of Helsinki University, Finland, and colleagues estimated the long-term risk of ESRD and death in patients with type 1 diabetes and assessed how age at diagnosis of diabetes, time period of diagnosis, and sex affect these risks. The study included patients younger than 30 years at the time of being diagnosed with type 1 diabetes in Finland in 1965-1999 (n = 20,005), who were identified from the Finnish Diabetes Register. The group was followed from diagnosis of diabetes until development of ESRD (dialysis or kidney transplantation as identified from the Finnish Registry for Kidney Diseases), death, or end of follow-up on December 31, 2001.

The median follow-up time after diagnosis was 16.7 years, with a maximum of 37 years. During the follow-up period, there were 632 cases of ESRD and 1,417 deaths. The researchers found that the cumulative incidence among all type 1 diabetic patients was 2.2 percent at 20 years and 7.8 percent at 30 years after diagnosis. Patients of both sexes diagnosed as having type 1 diabetes before age 5 years had a smaller risk of developing ESRD (3.3 percent after 30 years) than other patients (8.4 percent). The risk of ESRD was lower for patients diagnosed as having type 1 diabetes in later years. The risk did not differ significantly between sexes.

Patients with ESRD had 13.1 times the risk of death compared with other patients with type 1 diabetes when adjusting for age, sex, and time period of diabetes diagnosis. "This emphasizes the severity of ESRD as a complication of diabetes," the authors write. The cumulative death rate was 6.8 percent at 20 years and 15.0 percent at 30 years after diagnosis of type 1 diabetes. The cumulative risk of dying with ESRD was 0.7 percent at 20 years and 3.3 percent at 30 years after diagnosis of type 1 diabetes. The risk of death increased with age at diagnosis. The time period for the diagnosis of diabetes strongly affected survival: patients with diagnosis in 1975-1979 had 48 percent lower risk of dying than those with diagnosis in 1965-1969.

"In conclusion, our data indicate improved prognosis of type 1 diabetes with regard to both ESRD and death," the researchers write. "The overall incidence of ESRD appears to be lower than previously reported."
-end-
(JAMA.2005; 294:1782-1787. Available pre-embargo to the media at www.jamamedia.org)

Editor's Note: Dr. Finne was supported with a grant from the Liv och Hälsa Foundation.

The JAMA Network Journals

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.